powder and solvent for injection menveo conjugate meningococcal groups a, c, w135 and y

• 1. C/Y/W135群脑膜炎球菌多糖精制工艺 [P] . 中国专利： CN102911285B . 2014.03.19
• 2. C/Y/W135群脑膜炎球菌多糖精制工艺 [P] . 中国专利： CN102911285A . 2013-02-06
• 3. Menveo powder and solution for injection - meningococcal conjugate vaccine groups A, C, W135 and Y [P] . LU92108I2 . 2013-01-29

  机译： Menveo粉末和注射液-脑膜炎球菌结合疫苗A，C，W135和Y组

• 4. menveo group w135 meningococcal oligosaccharide conjugated to crm197 of corynebacterium diphtheriae. [P] . LU91733I9 . 2019-01-07

  机译： 与白喉棒状杆菌crm197缀合的脑膜炎球菌w135脑膜炎寡糖组。

• 5. Menveo - meningococcal vaccine groups A, C, W135 and Y conjugate. [P] . LU91778I2 . 2011-03-14

  机译： Menveo-脑膜炎球菌疫苗A，C，W135和Y结合物。

• 1. Preparation and Immunogenicity of Serogroup B Meningococcal OS-OMPC Conjugates [J] . SUN YIN-YAN, HU XU-JING 生物医学与环境科学（英文版） . 1999,第004期
• 2. Meningococcal quadrivalent (serogroups A, C, W135, and Y) conjugate vaccine (Menveo((R))): profile report. [J] . Deeks ED Pediatric drugs . 2012,第1期
• 3. Meningococcal quadrivalent (serogroups A, C, w135, and y) conjugate vaccine (Menveo): in adolescents and adults. [J] . Deeks ED BioDrugs: Clinical immunotherapeutics, biopharmaceuticals, and gene therapy . 2010,第5期
• 4. Antibody responses to meningococcal (groups A, C, Y and W135) polysaccharide diphtheria toxoid conjugate vaccine in children who previously received meningococcal C conjugate vaccine [J] . Bashir HE, Heath PT, Papa T, Vaccine . 2006,第14期
• 5. A Study on the Optimization of Solvent Debinding Process for Powder Injection Molded 316L Stainless Steel Parts [C] . MUHAMMAD Aslam, FAIZ Ahmad, P. S. M. BM-Yousoff, Advanced Materials Conference . 2016
• 6. Control of structural integrity and microstructural evolution in powder injection-molded alumina through the interaction between binder and powder. [D] . Lin, Shun-Tian Paul. 1991
• 7. Critical appraisal of a quadrivalent CRM197 conjugate vaccine against meningococcal serogroups A C W-135 and Y (Menveo®) in the context of treatment and prevention of invasive disease [O] . Michael Bröker, Brian Cooper, Lisa M DeTora, 2011
• 8. Critical appraisal of a quadrivalent CRM197 conjugate vaccine against meningococcal serogroups A, C W-135 and Y (Menveo®) in the context of treatment and prevention of invasive disease [O] . Bröker, Michael, Cooper, Brian, DeTora, Lisa M, 2011

• 1. Solvent de binding of water soluble binder in powder injection moulding [J] . Li Songlin(李松林) ,Huang Baiyun(黄伯云) ,Qu Xuanhui(曲选辉) . 中国有色金属学会会刊：英文版 . 1999,第3期
• 2. Development of a Multi-Plex Electrochemiluminescent Assay for the Detection of Serum Antibody Responses to Meningococcal Conjugate Vaccines [J] . Lani Indrawati ,Jon H. Heinrichs ,Emily P. Wen . 疫苗（英文） . 2012,第1期
• 3. Influence of current injection ways on efficiency and size of powders in preparation of nano-powders with electrical explosion [J] . Zhang Aihua ,Wu Long ,Yang Fulong . 中国焊接 . 2014,第001期
• 4. Injection molding and debinding of micro gears fabricated by micro powder injection molding [J] . Xin-lei Ni ,Hai-qing Yin ,Lin Liu . 矿物冶金与材料学报 . 2013,第001期
• 5. A/C/Y/W135群脑膜炎球菌多糖疫苗安全性及免疫原性人群考察 [C] . 李亚南 ,朱凤才 ,郭志军 . 2010年中国药学大会暨第十届中国药师周大会 . 2010
• 6. 流脑W135群,Y群结合疫苗的初步研制 [A] . 李法 . 2012